CancerWorld shared a post on X:
“Is Cancer Innovation Always Delivering What Patients Truly Need
As precision medicine, immunotherapy, and cellular therapies transform oncology, many patients still face marginal benefit, significant toxicity, time and financial burden, and unequal access to care. This article introduces the Common Sense Oncology movement, a global effort to redefine progress around outcomes that matter most: overall survival, quality of life, transparency, and equity.
Drawing on evidence, policy analysis, and international leadership within CSO, the piece challenges clinicians, researchers, regulators, and policymakers to ask a simple but essential question: Is this innovation meaningfully improving patients’ lives?
Read the full CancerWorld article by Adriana Albini here.”
More from CancerWorld.